Tag: AFib

FDA Grants De Novo Authorization to OMRON Healthcare for New Blood Pressure Monitors with AI-Powered AFib Detection Feature

Advancing its Going for Zero mission, OMRON innovation makes AFib screening an integral part of the brand’s routine home blood pressure monitoring experience HOFFMAN ESTATES, Ill., Nov. 14, 2024 /PRNewswire/ — In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare…

St. Joseph’s Hospital’s ‘Tampa 2’ AFib Procedure Contributes to Tampa Bay Legacy of Success

The Tampa 2 procedure was created to be easy to replicate while achieving equal or better outcomes compared to the Cox-Maze IV, a widely used surgical intervention for AFib introduced in 2002. AFib is a cardiac condition noted by an irregular, frequently rapid heart rhythm and is typically treated with prescription, catheter-based and/or surgical interventions. 
“We created the Tampa 2 procedure after years of collaboration between cardiology and cardiac surgery in conjunction with surgical pioneer Dr. James Cox (originator of the Cox-Maze IV procedure). This state-of-the-art technique has the potential to redefine surgical management of atrial fibrillation,” said Dr. Sherman.
Like its predecessor, the Tampa 2 creates scar tissue to block abnormal electrical signals that cause AFib but adds two lines of ablation (the method to create scar tissue) and has a different approach made possible by new tools and technology. The Tampa 2 achieved its namesake because of the two additional lines of ablation, developed by two Tampa physicians, all while tipping their hat to the success the Tampa Bay Buccaneers had with their Tampa 2 defense. More than 50 successful Tampa 2 procedures have been performed at St. Joseph’s Hospital, including the treatment of Brittany Williams, a patient of Dr. Sherman. Now the benefits of the Tampa 2 procedure extend beyond the walls of St. Joseph’s Hospital as Dr. Sherman and Dr. Makati host lectures across the country to train physicians on all aspects of AFib treatment. In addition, the two physicians presented their procedure and clinical findings at the 2024 International Society for Minimally Invasive Cardiothoracic Surgery annual meeting in Athens, Greece (see abstract here).”We are very proud that this novel procedure was developed here at BayCare and St. Joseph’s Hospital,” said Dr. Makati. “We are excited to continually offer new, lifesaving procedures to our community and beyond. This is only possible by the innovative spirit and collaborative efforts of our colleagues here in Tampa and around the world.” For more information about the Heart Institute at St. Joseph’s Hospital: https://baycare.org/locations/hospitals/st-josephs-hospital/services/heart-and-vascular About St. Joseph’s HospitalSt. Joseph’s Hospital, part of the BayCare Health System, is known for advanced medical technology and compassionate care. Its Centers of Excellence include the Heart and Vascular Institute, Cancer Institute, Stroke and Neuroscience Program, Robotic Surgery Program and Emergency/Trauma Department, which provides more emergency care than any other hospital in Tampa Bay. More than 70 specialties are represented among the medical team, including internal medicine, cardiovascular surgery and neurosurgery. The hospital was founded in 1934 by the Franciscan Sisters of Allegany. The 615-bed hospital is located at 3001 West Dr. Martin Luther King Jr. Boulevard in Tampa, Florida. For more information: BayCare.org/SJH.About BayCareBayCare is a leading not-for-profit health care system that connects individuals and families to a wide range of services at 16 hospitals and hundreds of other convenient locations throughout the Tampa Bay and central Florida regions. The system is West Central Florida’s largest provider of behavioral health and pediatric services and its provider group, BayCare Medical Group, is one of the largest in the region. BayCare’s diverse network of ambulatory services includes laboratories, imaging, surgical centers, BayCare Urgent Care locations, wellness centers and one of Florida’s largest home care agencies, BayCare HomeCare. BayCare’s mission is to improve the health of all it serves through community-owned, health care services that set the standard for high-quality, compassionate care. For more information visit BayCare.org.SOURCE BayCare Health System

Cardiovascular Centers of America Announces Cardiac Ablation Service Line at Advanced Heart and Vascular in Deltona, Florida

DELTONA, Fla., April 17, 2024 /PRNewswire/ — Cardiovascular Centers of America (CCA) proudly announces the launch of Florida’s the first complete cardiac ablation service line in an Ambulatory Surgery Center (ASC) at Advanced Heart and Vascular Surgery Center (Advanced Cardiovascular)….

GE HealthCare Launches CardioVisio for Atrial Fibrillation, a Digital, Patient-Centric Clinical Decision Support Tool to Enable Precision Care

CHICAGO–(BUSINESS WIRE)–Today, GE HealthCare (Nasdaq: GEHC) announces the launch of CardioVisio for Atrial Fibrillation (AFib), a digital tool designed to assist clinicians in visualizing longitudinal data relevant for disease progression from multiple data sources, and driving evidence based clinical decision […]

Progressing Clinical Evidence: CathVision Announces First Patient Enrolled In Persistent AF Study at OLV Hospital Aalst

Series of Clinical Studies Highlight Advantages of ECGenius System and CARDIALYTICS Suite of Algorithms COPENHAGEN, Denmark, April 17, 2023 /PRNewswire/ —  CathVision, a medical technology company developing innovative electrophysiology solutions to enhance clinical decision-making in the EP lab, today announced initial patient […]

Novel Medtronic Affera™ Mapping and Ablation System with the Sphere-9™ Catheter Demonstrates Safety and Performance for the Treatment of Atrial Fibrillation

12-month results reinforce versatility and durability for the treatment of paroxysmal and persistent AFib with the first-of-its-kind pulsed field ablation, radiofrequency, and high density mapping Sphere-9™ Catheter Medtronic today announced the 12-month findings that supported the Affera™ Mapping and Ablation […]

Vizient Examines Care Models for Arrhythmia, How to Improve Screening Rates for Colorectal Cancer in Latest Medical Device Tech Watch

IRVING, Texas–(BUSINESS WIRE)–Vizient, Inc. released its latest Medical Device Tech Watch, examining care models for cardiac arrhythmia, methods for improving colorectal cancer screening rates and how optimizing surgical tray standardization can reduce costs and improve operational efficiencies. Access Medical Device Tech Watch. […]

New Data Demonstrates vMap’s Use Associated with Significantly Improved Outcomes in Atrial Fibrillation Treatment Study

Targeted, driver-site ablation in conjunction with pulmonary vein isolation (PVI) achieves 87.5% freedom from atrial fibrillation (AF) and atrial tachycardia (AT) in complex AF patients versus 58.0% for PVI-only control SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the world’s only technology […]